FDA Inspection 1208127 — Reproductive Endocrinology Associates of Charlotte
The FDA completed an inspection of Reproductive Endocrinology Associates of Charlotte on May 11, 2023 in Charlotte, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 11, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Charlotte, NC (United States)